Clinical Trial Update: Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and pharmacokinetics of subcutaneous OCTA101 in adults with Hemophilia A; the study was terminated but results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• OCTA101

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-02-13